Treace Medical Concepts Inc (TMCI)
$7.75 -0.08 (-1.02%)| Market Cap | 525.37M |
| Revenue (ttm) | 209.36M |
| Net Income (ttm) | -55.74M |
| EPS (ttm) | N/A |
| PE Ratio | 0.00 |
| Forward PE | N/A |
| Profit Margin | -26.62% |
| Debt to Equity Ratio | 0.47 |
| Volume | 776,600 |
| Avg Vol | 423,624 |
| Day's Range | N/A - N/A |
| Shares Out | 62.62M |
| Stochastic %K | 44% |
| Beta | 0.77 |
| Analysts | Sell |
| Price Target | $11.29 |
Latest News on TMCI
Mar 28, 2025, 2:00 PM EDT - 8 days ago
Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference
Mar 25, 2025, 4:15 PM EDT - 11 days ago
Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference
Mar 1, 2025, 11:00 AM EST - 5 weeks ago
The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation
Feb 28, 2025, 1:11 PM EST - 5 weeks ago
Treace Medical Concepts, Inc. (TMCI) Q4 2024 Earnings Call Transcript
Feb 6, 2025, 4:15 PM EST - 2 months ago
Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
Feb 2, 2025, 11:00 AM EST - 2 months ago
The Schall Law Firm Invites Investors With Losses To Join An Investigation Into Treace Medical Concepts, Inc. For Securities Fraud
Jan 30, 2025, 11:00 AM EST - 2 months ago
Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm
Jan 23, 2025, 12:45 PM EST - 2 months ago
Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
Jan 19, 2025, 11:00 AM EST - 2 months ago
Treace Medical Concepts, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm
Jan 18, 2025, 11:15 AM EST - 2 months ago
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
Jan 9, 2025, 12:07 PM EST - 3 months ago
The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
Jan 3, 2025, 1:15 PM EST - 3 months ago
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts Inc For Securities Fraud
Jan 2, 2025, 4:15 PM EST - 3 months ago
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference
Dec 31, 2024, 12:30 PM EST - 3 months ago
The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts Inc For Securities Fraud
Dec 30, 2024, 8:15 AM EST - 3 months ago
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure
Dec 27, 2024, 1:45 PM EST - 3 months ago
The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Treace Medical Concepts Inc For Securities Fraud
Dec 24, 2024, 10:45 AM EST - 3 months ago
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts Inc For Securities Fraud
Dec 17, 2024, 1:30 PM EST - 3 months ago
The Schall Law Firm Urges Stockholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
Dec 16, 2024, 8:30 AM EST - 3 months ago
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
Dec 15, 2024, 5:15 PM EST - 3 months ago
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
Dec 13, 2024, 5:15 PM EST - 4 months ago
The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
Dec 11, 2024, 5:45 PM EST - 4 months ago
The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
Dec 11, 2024, 10:49 AM EST - 4 months ago
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm